LEP and autoimmune disease: Our results provide evidence for an anti-inflammatory role of leptin in childhood ITP and suggest that elevated levels of a soluble mediator in the acute phase of an autoimmune disease should not necessarily be considered as causative of disease pathogenesis but should instead be investigated for an immunomodulatory function.